TABLE 2.
Type of drug use | Total participants* (%) (n = 624) | Total events (n = 3703) |
---|---|---|
Non-injection opioids | 378 (60.6) | 904 |
Non-injection diverted prescription opioids | 273 (43.8) | 505 |
Non-injection heroin | 249 (39.9) | 571 |
Non-injection stimulants | 601 (96.3) | 3155 |
Non-injection crack cocaine | 535 (85.7) | 2758 |
Non-injection cocaine | 301 (48.2) | 589 |
Non-injection crystal methamphetamine | 285 (45.7) | 757 |
Injection opioids | 394 (63.1) | 1913 |
Injection diverted prescription opioids | 173 (27.7) | 343 |
Injection heroin | 385 (61.7) | 1878 |
Injection stimulants | 339 (54.3) | 1397 |
Injection crack cocaine | 80 (12.8) | 113 |
Injection cocaine | 258 (41.4) | 819 |
Injection crystal methamphetamine | 251 (40.2) | 895 |
Total # of participants who reported the type of drug use at least once in the last 6 months at baseline or any follow-up visit during the study period (2010–2017)